General Information
Version
6.1
Revision date
2022-10-02
Product name
3-hydroxyestra-1,3,5(10)-triene-16,17-dione 16-oxime
CAS No.
1314242-46-0
REACH No
A
Emergency telephone
+(47)-22591300, +(47)-21930678
Icons in SDS
Company Information
company name
Merck Life Science AS
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360FD, H362
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H351 Suspected of causing cancer. H360FD May damage fertility. May damage the unborn child. H362 May cause harm to breast-fed children. H351 Suspected of causing cancer. H362 May cause harm to breast-fed children. H360FD May damage fertility. May damage the unborn child.
Precautionary statements
P201 Obtain special instructions before use. P260 Do not breathe dusts or mists. P263 Avoid contact during pregnancy and while nursing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P201 Obtain special instructions before use. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Carcinogenicity (Category 2), H351 Reproductive toxicity (Category 1A), H360FD Effects on or via lactation, H362 For the full text of the H-Statements mentioned in this Section, see Section 16.
